Abstract:Xin Wang, 1, 2 Qianqian Liang, 1, 2 Zheng Li, 1â€“ 4 Fengsen Li 1â€“ 4 1 Department of Integrated Pulmonology, Fourth Clinical Medical College of Xinjiang Medical University, Urumqi, Xinjiang, People's Republic of China; 2 Xinjiang National Clinical Research Base of Traditional Chinese Medicine, Urumqi, Xinjiang, People's Republic of China; 3 Xinjiang Key Laboratory of Respiratory Disease Research, Urumqi, Xinjiang, People's Republic of China; 4 Xinjiang Clinical Medical Research Center of Respiratory Obstructive Diseases, Urumqi, Xinjiang, People's Republic of China Correspondence: Zheng Li; Fengsen Li, Tel +86-13999297797 ; +86-13999980996, Email ; The proportion of obese or overweight patients in COPD patients is increasing. Although BMI, WC and other easy to measure indicators have been proven to be related to the risk of COPD, they cannot accurately reflect the distribution and changes of body composition, ignoring the body composition (such as fat distribution, muscle content, water content, etc.), the relationship between it and disease risk may be missed. By analyzing the correlation between different body composition indexes and COPD patients, we can provide new research ideas for the prognosis judgment or intervention of COPD disease. Keywords: obesity, COPD, body composition, BMI, waist circumference, waist-to-hip ratio, body fat rate, visceral fat, FFMI, extracellular water, intracellular water, phase angle COPD is a pulmonary dysfunction marked by morbidity or comorbidities of progressive irreversible airflow obstruction, chronic airway inflammation, and systemic consequences, marked by ongoing respiratory symptoms and airflow restriction. Typically brought on by anomalies in the alveoli or the airways brought on by prolonged exposure to harmful chemicals or particles. 1 Despite the fact that BMI is linked to the risk of dying from COPD, the obesity paradox has recently brought attention back to the link between obesity and COPD. Although the correlation has been shown, BMI is unable to capture the association between COPD and body composition. The impact of BMI, WC, FFMI, PhA, body fat percentage, visceral fat, and body water on COPD is covered in this article. The development of the research is outlined as follows. The obesity paradox states that while a high BMI has a considerable protective effect on the prognosis of COPD, a low BMI level will hasten the decrease of lung function. 2,3 Obesity is also strongly associated with a higher risk of death and prevalence. 4 Overweight or obese individuals make up for 65% of COPD patients. 5 For every 5kg/m2 rise in BMI over the normal range [(22â€“25) kg/m2], the proportional increase in all-cause mortality is similarly larger, will increase 30% level of studies that correlate medical expenditures. 6,7 In a study comparing BMI to GOLD scores, 8 it was discovered that there was a U-shaped association between BMI and spending in GOLD grades 1â€“3, but in GOLD grade 4, health care spending reduced virtually linearly as BMI rose. Low BMI raises the risk of exacerbations and lowers COPD survival rates. 9,10 Furthermore, lower BMI has been linked to worsened COPD and increased mortality. 11 Low socioeconomic level, poor health, inadequate physical exercise, and recurring illnesses are all frequently linked to low BMI. The risk of COPD exacerbation and possibly death can be decreased by maintaining a normal body mass index. 12 Weaker respiratory muscles may increase the chance of COPD flare-ups and also decrease airway ventilation and load capacity. 13,14 Increased body weight also increases the respiratory muscles' effectiveness. It is being investigated in ECLIPSE (COPD Longitudinal Assessment to Determine Predictive Surrogate Endpoints), 15 obese individuals have considerably higher serum levels of TNF-Î±, interleukin (IL)-6, leptin, and c-reactive protein (CRP), which was 3.3 times greater compared to patients of normal weight, and COPD participants are related with persistent systemic inflammation. Although BMI is frequently employed as a marker for determining the severity of a disease, BMI is unable to reflect the distribution of body fat, muscle, and other tissues, which will cause us to miss the association between fat distribution and illness risk. Future studies evaluating the association between obesity and mortality should go beyond BMI and take into account the distribution of body composition for the advancement of COPD. Relevant conclusions in the literature are shown in Table 1, and the literature from 2009 to 2020. Table 1 Conclusions Related to BMI Indicators of abdominal fat content include WC, which is also used -Abstract Truncated-

Genome-wide association analysis of body mass in chronic obstructive pulmonary disease.

BMI-related Genetic Factors and COPD Imaging Phenotypes

Genetically Predicted Body Mass Index and Mortality in COPD

WHOLE GENOME SEQUENCING ANALYSIS OF BODY MASS INDEX IDENTIFIES NOVEL AFRICAN ANCESTRY-SPECIFIC RISK ALLELE

Multi-ancestry Genome-Wide Association Analyses Improve Resolution of Genes and Pathways Influencing Lung Function and Chronic Obstructive Pulmonary Disease Risk

Genetic modifiers of body mass index in individuals with cystic fibrosis

Association between appendicular lean mass and chronic obstructive pulmonary disease: epidemiological cross-sectional study and bidirectional Mendelian randomization analysis

Integrating Genetic and Transcriptomic Data to Identify Genes Underlying Obesity Risk Loci

A large-scale genome-wide association analysis of lung function in the Chinese population identifies novel loci and highlights shared genetic aetiology with obesity

FTO Genetic Variants, Dietary Intake and Body Mass Index: Insights from 177,330 Individuals.

Body Composition and COPD: A New Perspective

Genomics and Phenomics of Body Mass Index Reveals a Complex Disease Network

Body Mass Index of Patients with Chronic Obstructive Pulmonary Disease is Associated with Pulmonary Function and Exacerbations: a Retrospective Real World Research.

Pleiotropy of Genetic Variants on Obesity and Smoking Phenotypes: Results from the Oncoarray Project of the International Lung Cancer Consortium

New genetic signatures associated with cancer cachexia as defined by low skeletal muscle index and weight loss

A genetic locus within the FMN1/GREM1 gene region interacts with body mass index in colorectal cancer risk

Assessing the contribution of rare genetic variants to phenotypes of chronic obstructive pulmonary disease using whole-genome sequence data

A cross-omics integrative study of metabolic signatures of chronic obstructive pulmonary disease

A Large Multiethnic Genome-Wide Association Study of Adult Body Mass Index Identifies Novel Loci

Multi-ancestry genome-wide association study reveals novel genetic signals for lung function decline

Voltage utilization in Model Predictive Control for IPMSM